Publications
- Cardiovascular effects of GLP-1 receptor agonist treatment: focus on liraglutide2015 | First Faculty of Medicine
- Insulin therapy and cardiovascular complications2013 | First Faculty of Medicine
- Cardiovascular effects of glukagon-like peptide-1 and its agonist: more than just cardiovascularly safe antidiabetics?2012 | First Faculty of Medicine
- Antidiabetic drugs and cardiovascular risk - before and now2012 | First Faculty of Medicine
- Metabolic syndrome and stroke2011 | First Faculty of Medicine
- Propafenone versus amiodarone for supraventricular arrhythmias in septic shock: a randomised controlled trial2023 | First Faculty of Medicine, Third Faculty of Medicine
- Akutní stavy ve vnitřním lékařství2022 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Pilsen
- The impact of obesity on the outcome of severe SARS-CoV-2 ARDS in a high volume ECMO centre: ECMO and corticosteroids support the obesity paradox2022 | First Faculty of Medicine
- The effect of high-flow arteriovenous fistulas on systemic haemodynamics and brain oxygenation2021 | First Faculty of Medicine
- Reduction of arteriovenous access blood flow leads to biventricular unloading in haemodialysis patients2021 | First Faculty of Medicine
Loading network view...